Serial #88693707
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #88693707 Trademark

Serial Number: 88693707 • Registration: 6392382

Serial #88693707 is a trademark filed by Slayback Pharma Limited Liability Company on November 15, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Slayback Pharma Limited Liability Company (11 trademarks)

Suite 303
Princeton, NJ 08540

Entity Type: 16

AZURITY PHARMACEUTICALS, INC. (89 trademarks)

WOBURN, MA 01801

Entity Type: 03

Trademark Details

Filing Date

November 15, 2019

Registration Date

June 22, 2021

Published for Opposition

April 6, 2021

Goods & Services

pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of cardiovascular disorders, allergies, anaphylaxis, central nervous system disorders, peripheral nervous system disorders, reproductive health disorders, electrolytic imbalance, caloric imbalance, obesity, nutritional disorders, autoimmune disorders, endocrine disorders, gastrointestinal disorders, inflammatory disorders, dermatological disorders, infectious diseases, hormonal imbalance, pain, complications arising from organ transplantation, cancer, pulmonary disorders, renal disorders, urinary system disorders, ophthalmic disorders, otic disorders, sense organ disorders, dental disorders, musculoskeletal disorders, diabetic disorders, neuromuscular disorders, bone disorders, blood disorders, metabolic disorders, psychosis; pharmaceutical drugs, preparations and medications for use in sedation, analgesia, anaesthesia; pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of senile disorders, sleep disorders, dementia, congenital disease disorders, abnormal gene disorders, hair growth disorders, gynaecological diseases, obstetric disorders, withdrawal syndromes, hormonal disorders, urogenital organ disorders, sexual dysfunction, nausea and vomiting, emesis, migraine, edema, multiple sclerosis, chronic obstructive pulmonary disorder, depression, pregnancy, spasms, hypertension, hypotension, angioedema, fungal diseases, fertility disorders, hyperglycemia, hypoglycemia, post-operative disorders, arthritis, psoriasis and localized fat deposits; pharmaceutical and biological preparations for use in diagnosis, namely, for use as and X-ray contrast reagents

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 19, 2025 ASCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 5, 2025 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 16, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 16, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 16, 2024 COAR
REGISTERED-PRINCIPAL REGISTER
Jun 22, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 6, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 8, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 9, 2020 GNFN
FINAL REFUSAL E-MAILED
Sep 9, 2020 GNFR
FINAL REFUSAL WRITTEN
Sep 9, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 18, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 22, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2019 NWOS
NEW APPLICATION ENTERED
Nov 19, 2019 NWAP